within Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EC03_Dorzolamide;

model Dorzolamide
  extends Pharmacolibrary.Drugs.ATC.S.S01EC03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>S01EC03</td></tr><td>route:</td><td>ophthalmic</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dorzolamide is a carbonic anhydrase inhibitor primarily used as an ophthalmic solution to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is approved and widely used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers (ophthalmic administration). Dorzolamide accumulates in erythrocytes due to high affinity for carbonic anhydrase II. Minimal systemic exposure due to local ocular administration.</p><h4>References</h4><ol><li><p>Martens-Lobenhoffer, J, &amp; Banditt, P (2002). Clinical pharmacokinetics of dorzolamide. <i>Clinical pharmacokinetics</i> 41(3) 197–205. DOI:<a href=\"https://doi.org/10.2165/00003088-200241030-00004\">10.2165/00003088-200241030-00004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11929320/\">https://pubmed.ncbi.nlm.nih.gov/11929320</a></p></li><li><p>Frampton, JE, &amp; Perry, CM (2006). Topical dorzolamide 2%/timolol 0.5% ophthalmic solution: a review of its use in the treatment of glaucoma and ocular hypertension. <i>Drugs &amp; aging</i> 23(12) 977–995. DOI:<a href=\"https://doi.org/10.2165/00002512-200623120-00005\">10.2165/00002512-200623120-00005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17154662/\">https://pubmed.ncbi.nlm.nih.gov/17154662</a></p></li><li><p>Kadam, RS, et al., &amp; Kompella, UB (2011). Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 39(9) 1529–1537. DOI:<a href=\"https://doi.org/10.1124/dmd.111.040055\">10.1124/dmd.111.040055</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21673129/\">https://pubmed.ncbi.nlm.nih.gov/21673129</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Dorzolamide;
